Catalyst Wire Dossier Catalyst Wire Dossier

ProHema CB

· Fate Therapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ProHema CB, covering 2018-10-10 to 2018-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies [Phase 1]

See pricing